Comparison
NMN vs Lutein + Zeaxanthin
NMN
Nicotinamide mononucleotide — NAD+ precursor. Studied for cellular aging and metabolic health.
Lutein + Zeaxanthin
Macular carotenoids that protect retinal tissue from oxidative damage. Multiple RCTs support reduced age-related macular degeneration progression.
| Field | NMN | Lutein + Zeaxanthin |
|---|---|---|
| Category | neuroprotective | neuroprotective |
| Dose range | 250–1000mg | 10–20mg |
| Half-life | — | — |
| Onset | — | — |
| Evidence | EVIDENCEB | EVIDENCEA |
| Safety | ●●●●● | ●●●●● |
| Legal (US) | USOTC | USOTC |
| PubMed refs | 600 | 3500 |
The comparison in plain English
Auto-generated from dataNMN and Lutein + Zeaxanthin are both in the neuroprotective category respectively. NMN Nicotinamide mononucleotide — NAD+ precursor. Lutein + Zeaxanthin Macular carotenoids that protect retinal tissue from oxidative damage.
Bottom line
NMN (evidence B, safety 5/5) has a stronger evidence base than Lutein + Zeaxanthin (evidence A, safety 5/5). NMN has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.
Choose NMN if
NMN is the better fit when your goal aligns with its mechanism (Direct precursor to NAD+ — one biosynthetic step closer than nicotinamide riboside, bypassing the NRK1/NRK2 enzymatic step) and the dose range (250–1000mg) suits your protocol. Half-life is —h.
Choose Lutein + Zeaxanthin if
Lutein + Zeaxanthin is the better fit when your goal aligns with its mechanism (Concentrated in the macula lutea (yellow spot) of the retina, where they absorb high-energy blue light and quench reactive oxygen species) and the dose range (10–20mg) suits your protocol. Half-life is —h.